- Cochrane Italy
Have you or someone you know well been affected by Mild Cognitive Impairment or Mild Dementia, due to probable or possible Alzheimer Disease?
Skills / interests: Review development, Patient and public input
Would you be interested in helping us with a Cochrane systematic review focused on amyloidβ-targeting monoclonal antibodies (Aβ-mAbs) for the treatment of people with Mild Cognitive Impairment (MCI) or mild dementia due to Alzheimer’s disease (AD)?
We are looking for a consumer who would be willing to join our Cochrane systematic review, supporting the author team with:
- Carrying out the review;
- Interpretation of the review findings;
- Drafting of the Plain Language Summary.
Cochrane considers a consumer to be a person with experience of the condition (in this case, MCI or mild dementia due to Alzheimer’s disease), either as a patient or as a carer/family member of a patient.
If you any questions and would like more info about the task, write to cochrane.italia@ausl.bologna.it